| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Inventory, net | 3,251,355 | |||
| Other current assets | 1,964,974 | |||
| Product deposit | 251,000 | |||
| Cash | 36,228,305 | |||
| Accounts receivable, net | 7,330,129 | |||
| Total current assets | 49,025,763 | |||
| Equipment, net | 2,050,318 | |||
| Right of use assets | 5,822,907 | |||
| Intangible assets, net | 1,827,768 | |||
| Capitalized software, net | 14,837,946 | |||
| Total non-current assets | 24,538,939 | |||
| Total assets | 73,564,702 | |||
| Accrued expenses | 14,946,499 | |||
| Current operating lease liabilities | 541,981 | |||
| Deferred revenue | 11,790,024 | |||
| Current portion of long-term debt | 11,960,784 | |||
| Accounts payable | 24,292,870 | |||
| Total current liabilities | 63,532,158 | |||
| Noncurrent operating lease liabilities | 6,032,847 | |||
| Long-term debt, net | 3,517,317 | |||
| Contingent consideration | 100,000 | |||
| Total liabilities | 73,182,322 | |||
| Treasury stock, 103,040, at cost, as of june 30, 2025 and december 31, 2024 | 163,701 | |||
| Accumulated deficit | -238,496,413 | |||
| Series a preferred stock, 0.0001 par value 1,610,000 shares authorized, 1,400,000 shares issued and outstanding, liquidation value approximately, 25.55 per share as of june 30, 2025 and december 31, 2024 | 140 | |||
| Common stock, 0.01 par value 100,000,000 shares authorized, 45,141,226 and 42,293,907 shares issued, 45,038,186 and 42,190,867 outstanding as of june 30, 2025 and december 31, 2024, respectively | 451,412 | |||
| Additional paid-in capital | 236,426,008 | |||
| Total lifemd, inc. stockholders deficit | -1,782,554 | |||
| Non-controlling interest | 2,164,934 | |||
| Total stockholders equity (deficit) | 382,380 | |||
| Total liabilities, mezzanine equity and stockholders equity (deficit) | 73,564,702 | |||
LifeMD, Inc. (LFMD)
LifeMD, Inc. (LFMD)